Regeneron Pharmaceuticals’ $256 million offer was chosen the winner of 23andMe’s bankruptcy auction. Drug research never ...

Threat actors continue to refine their strategies, and the financial incentives for cybercrime persist. However, the combination of stronger defenses, regulatory pressure, and industry collaboration ...

President Trump’s executive order provides a framework for tying the prices of U.S. pharmaceutical products to the lower ...

Robert F. Kennedy Jr. testified before the House Committee on Appropriations and the Senate Health, Education, Labor and ...

UnitedHealth Group announced that Andrew Witty will step down as CEO due to “personal reasons.” He is being replaced by ...

GSK is expanding its prospects in hepatology, paying $1.2 billion to acquire a drug that goes after a clinically validated liver target but with a dosing advantage that could give it a competitive ...

Trust in the U.S. healthcare system is eroding, but experts say rebuilding it is possible. They say this will require both ...

After years of limited activity, the digital health sector is finally showing signs of life in the public markets. Only a few companies have filed to go public in recent years, including Waystar ...

When I was in business school in 2016, I wrote a composition on Blockchain and its implications in healthcare. At the time, all the experts proclaimed confidently that this new technology would ...

Withings Health Solutions and Babyscripts announced a partnership Thursday that aims to address hypertensive disorders of pregnancy, which are among the leading causes of maternal mortality.